Literature DB >> 12419232

Design, activity, and structure of a highly specific artificial endonuclease.

Brett S Chevalier1, Tanja Kortemme, Meggen S Chadsey, David Baker, Raymond J Monnat, Barry L Stoddard.   

Abstract

We have generated an artificial highly specific endonuclease by fusing domains of homing endonucleases I-DmoI and I-CreI and creating a new 1400 A(2) protein interface between these domains. Protein engineering was accomplished by combining computational redesign and an in vivo protein-folding screen. The resulting enzyme, E-DreI (Engineered I-DmoI/I-CreI), binds a long chimeric DNA target site with nanomolar affinity, cleaving it precisely at a rate equivalent to its natural parents. The structure of an E-DreI/DNA complex demonstrates the accuracy of the protein interface redesign algorithm and reveals how catalytic function is maintained during the creation of the new endonuclease. These results indicate that it may be possible to generate novel highly specific DNA binding proteins from homing endonucleases.

Mesh:

Substances:

Year:  2002        PMID: 12419232     DOI: 10.1016/s1097-2765(02)00690-1

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  83 in total

1.  A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells.

Authors:  Jean-Charles Epinat; Sylvain Arnould; Patrick Chames; Pascal Rochaix; Dominique Desfontaines; Clémence Puzin; Amélie Patin; Alexandre Zanghellini; Frédéric Pâques; Emmanuel Lacroix
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

2.  Structural and biochemical analyses of DNA and RNA binding by a bifunctional homing endonuclease and group I intron splicing factor.

Authors:  Jill M Bolduc; P Clint Spiegel; Piyali Chatterjee; Kristina L Brady; Maureen E Downing; Mark G Caprara; Richard B Waring; Barry L Stoddard
Journal:  Genes Dev       Date:  2003-11-21       Impact factor: 11.361

3.  Site-specific selfish genes as tools for the control and genetic engineering of natural populations.

Authors:  Austin Burt
Journal:  Proc Biol Sci       Date:  2003-05-07       Impact factor: 5.349

4.  Analysis of the LAGLIDADG interface of the monomeric homing endonuclease I-DmoI.

Authors:  George H Silva; Marlene Belfort
Journal:  Nucleic Acids Res       Date:  2004-06-09       Impact factor: 16.971

Review 5.  Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing.

Authors:  Manuel Kaulich; Steven F Dowdy
Journal:  Nucleic Acid Ther       Date:  2015-11-05       Impact factor: 5.486

6.  Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design.

Authors:  Louis A Clark; P Ann Boriack-Sjodin; John Eldredge; Christopher Fitch; Bethany Friedman; Karl J M Hanf; Matthew Jarpe; Stefano F Liparoto; You Li; Alexey Lugovskoy; Stephan Miller; Mia Rushe; Woody Sherman; Kenneth Simon; Herman Van Vlijmen
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

7.  Crystallization and preliminary X-ray diffraction analysis on the homing endonuclease I-Dmo-I in complex with its target DNA.

Authors:  Pilar Redondo; Jesús Prieto; Elena Ramos; Francisco J Blanco; Guillermo Montoya
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-21

8.  A de novo designed protein protein interface.

Authors:  Po-Ssu Huang; John J Love; Stephen L Mayo
Journal:  Protein Sci       Date:  2007-12       Impact factor: 6.725

9.  Generation of DNA cleavage specificities of type II restriction endonucleases by reassortment of target recognition domains.

Authors:  Sonata Jurenaite-Urbanaviciene; Jurgita Serksnaite; Edita Kriukiene; Jolanta Giedriene; Ceslovas Venclovas; Arvydas Lubys
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

10.  Rational design of a chimeric endonuclease targeted to NotI recognition site.

Authors:  Penghua Zhang; Yongming Bao; Lauren Higgins; Shuang-yong Xu
Journal:  Protein Eng Des Sel       Date:  2007-10-20       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.